Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study.
暂无分享,去创建一个
K. Baggerly | M. Konopleva | K. Patel | G. Borthakur | W. Stock | Helen H. W. Chen | N. Jain | M. Baer | Lina Han | Helen Ma | Yang Zhao | B. Ragon | O. Odenike | Loren J. Joseph